Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2025 16:02 ET | Source: Beta Bionics, Inc.

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial...
May 01, 2025 08:00 ET | Source: Beta Bionics, Inc.

Beta Bionics to Present at the Bank of America Securities Health Care Conference

IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management...
April 16, 2025 16:05 ET | Source: Beta Bionics, Inc.

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans...
April 09, 2025 07:30 ET | Source: Beta Bionics, Inc.

Beta Bionics to Host Investor Event on June 22, 2025

IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today...
March 27, 2025 16:45 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Board Appointment of Gerard Michel

IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the...
March 25, 2025 16:02 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial...
February 27, 2025 07:00 ET | Source: Beta Bionics, Inc.

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

IRVINE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans...
January 31, 2025 17:56 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of...
January 29, 2025 22:34 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized...
January 06, 2025 17:14 ET | Source: Beta Bionics, Inc.

Beta Bionics Files Registration Statement for Proposed Initial Public Offering

Beta Bionics, Inc., a leader in the development of advanced diabetes management solutions, announced that it has filed a Form S-1 with the SEC.

Next Page keyboard_arrow_right